Business Context and Reporting Period
This Form 6-K was filed by I-MAB, a foreign private issuer, for the month of April 2020 and signed on April 6, 2020. The filing identifies Shanghai, China as the principal executive-office location and states that I-MAB files annual reports on Form 20-F.
The provided text is the filing cover page and an exhibit index listing Exhibit 99.1, a press release. The press release itself is not included.
Financial Metrics
The provided filing text does not report revenue, profit or loss, cash flow, margins, debt, liquidity, operating expenses, cash balances, or other financial metrics.
Material Changes Versus the Prior Comparable Period
The filing text does not provide comparative-period financial or operating information and does not identify material changes.
Guidance, Outlook, Risks, and Unusual Items
The filing text does not provide guidance, outlook commentary, risk disclosures, contingencies, or unusual items. Any substantive information may be contained in the referenced but unavailable Exhibit 99.1 press release.
Investor Verification Items
- Verify the registrant identity: the filing names I-MAB, while the request metadata names Novabridge Biosciences.
- Obtain and review Exhibit 99.1, the referenced press release.
- Verify any financial results, business updates, guidance, or risk disclosures in the complete filing materials.
- Confirm the reporting period and the relationship between the April 2020 filing month and any underlying event or financial period.